Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hirofumi OSADA
Efficacy of Levocarnitine Chloride (LC-80) in Treatment of Ischemic Heart Diseases by the Serial Multistage Treadmill Exercise Testing. A Multicenter Double-Blind Group-Comparison Study.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Related publications
Efficacy of Nadolol (PS-527) in Treatment of Angina Pectoris. A Multicenter Double-Blind Group-Comparison Study.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Evaluation of Antianginal Effects of Isosorbide 5-Mononitrate (TY-10368) With Serial Multistage Treadmill Exercise Testing.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Clinical Evaluation of Antianginal Effects of Celiprolol (NBP-582) With Treadmill Exercise Testing. A Randomized Double-Blind Crossover Study in Comparison With Placebo.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
The Prognostic Significance of Serial Treadmill Exercise Testing After Myocardial Infarction
The KITAKANTO Medical Journal
HL301 in the Treatment of Acute Bronchitis: A Phase 2b, Randomized, Double-Blind, Placebocontrolled, Multicenter Study
Korean Journal of Internal Medicine
Internal Medicine
Clinical Evaluation of Antianginal Effects of Carvediol (DQ-2466) With Treadmill Exercise Testing in Patients With Effort Angina Pectoris. A Randomized Double-Blind Cross-Over Study in Comparison With Placebo.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Efficacy and Safety of Two pH-dependent-release Mesalamine Doses in Moderately Active Ulcerative Colitis: A Multicenter, Randomized, Double-Blind, Parallel-Group Study
Intestinal Research
Gastroenterology
A Double-Blind, Randomized, Multicenter, Italian Study of Frovatriptan Versus Almotriptan for the Acute Treatment of Migraine
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
Clinical Efficacy of Fidarestat, a Novel Aldose Reductase Inhibitor, for Diabetic Peripheral Neuropathy: A 52-Week Multicenter Placebo-Controlled Double-Blind Parallel Group Study
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes